Literature DB >> 30214600

Comparison of spatial chromosomal organization between bone marrow and peripheral blood in acute myeloid leukemia.

Xueli Tian1, Yanfang Wang2, Yu Liu1, Jun Yin1, Dieyan Chen1, Xiaoyan Ke2, Wanyun Ma1,3.   

Abstract

Acute myeloid leukemia associated with t(8;21)(q22;q22)/runt related transcription factor (RUNX)1-RUNX1 translocation partner 1 has been reported to exhibit a favorable outcome. The quantitative polymerase chain reaction is a reliable method for assessing minimal residual disease persistence, and peripheral blood (PB) samples are as informative as bone marrow (BM) samples during follow-up monitoring. However, few studies have compared the spatial organization of leukemia-specific chromosomes between BM and PB. In the present study, paired BM and PB samples were extracted from 6 patients with acute myeloid leukaemia-M2 and compared using three-dimensional fluorescence in situ hybridization. Cells were classified into three types: Normal, proximal and malignant. Comparisons of proportions (% of all cells) of different cell types revealed no significant difference between BM and PB samples. The relative radial positions (RRPs; d/R) of chromosomes 8 and 21 were consistent for 2/3 of BM and PB samples. The RRPs of chromosomes in proximal pairs were more interior in nuclei compared with chromosomes in normal pairs for BM and PB samples. The consistency of the spatial organization of chromosomes between BM and PB suggests that PB may be an alternative to BM for research and clinical diagnosis.

Entities:  

Keywords:  acute myeloid leukemia; bone marrow; peripheral blood; spatial organization; three-dimensional fluorescence in situ hybridization

Year:  2018        PMID: 30214600      PMCID: PMC6126258          DOI: 10.3892/ol.2018.9228

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

Authors:  V H J van der Velden; A Hochhaus; G Cazzaniga; T Szczepanski; J Gabert; J J M van Dongen
Journal:  Leukemia       Date:  2003-06       Impact factor: 11.528

Review 3.  Chromosome positioning in the interphase nucleus.

Authors:  Luis Parada; Tom Misteli
Journal:  Trends Cell Biol       Date:  2002-09       Impact factor: 20.808

4.  Minimal residual core binding factor AMLs by real time quantitative PCR--initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse.

Authors:  Jesper Stentoft; Peter Hokland; Mette Ostergaard; Henrik Hasle; Charlotte Guldborg Nyvold
Journal:  Leuk Res       Date:  2005-10-21       Impact factor: 3.156

5.  Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse.

Authors:  K Tobal; J Newton; M Macheta; J Chang; G Morgenstern; P A Evans; G Morgan; G S Lucas; J A Liu Yin
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

6.  Wide-scale alterations in interchromosomal organization in breast cancer cells: defining a network of interacting chromosomes.

Authors:  Andrew J Fritz; Branislav Stojkovic; Hu Ding; Jinhui Xu; Sambit Bhattacharya; Daniel Gaile; Ronald Berezney
Journal:  Hum Mol Genet       Date:  2014-05-15       Impact factor: 6.150

Review 7.  Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia.

Authors:  Francesco Buccisano; Luca Maurillo; Maria Ilaria Del Principe; Giovanni Del Poeta; Giuseppe Sconocchia; Francesco Lo-Coco; William Arcese; Sergio Amadori; Adriano Venditti
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

8.  Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21).

Authors:  H Leroy; S de Botton; N Grardel-Duflos; S Darre; X Leleu; C Roumier; F Morschhauser; J-L Lai; F Bauters; P Fenaux; C Preudhomme
Journal:  Leukemia       Date:  2005-03       Impact factor: 11.528

9.  Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.

Authors:  Eric Jourdan; Nicolas Boissel; Sylvie Chevret; Eric Delabesse; Aline Renneville; Pascale Cornillet; Odile Blanchet; Jean-Michel Cayuela; Christian Recher; Emmanuel Raffoux; Jacques Delaunay; Arnaud Pigneux; Claude-Eric Bulabois; Céline Berthon; Cécile Pautas; Norbert Vey; Bruno Lioure; Xavier Thomas; Isabelle Luquet; Christine Terré; Philippe Guardiola; Marie C Béné; Claude Preudhomme; Norbert Ifrah; Hervé Dombret
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

10.  Significance of spatial organization of chromosomes in the progression of acute myeloid leukemia.

Authors:  Xueli Tian; Yanfang Wang; Dieyan Chen; Xiaoyan Ke; Wanyun Ma
Journal:  Chin J Cancer       Date:  2017-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.